WeChat Mini Program
Old Version Features

Myocardial Infarction in Diffuse Large B‐cell Lymphoma Patients – a Population‐based Matched Cohort Study

JOURNAL OF INTERNAL MEDICINE(2021)

Karolinska Inst

Cited 10|Views13
Abstract
Background The outcome for diffuse large B-cell lymphoma (DLBCL) patients has improved with the immunochemotherapy combination R-CHOP. An increased rate of heart failure is well documented following this treatment, whereas incidence and outcome of other cardiac complications, for example myocardial infarction, are less well known. Method We identified 3548 curatively treated DLBCL patients in Sweden diagnosed between 2007 and 2014, and 35474 matched lymphoma-free general population comparators. The incidence, characteristics and outcome of acute myocardial infarctions (AMIs) were assessed using population-based registers up to 11 years after diagnosis. The rate of AMI was estimated using flexible parametric models. Results Overall, a 33% excess rate of AMI was observed among DLBCL patients compared with the general population (HR: 1.33, 95% CI: 1.14-1.55). The excess rate was highest during the first year after diagnosis and diminished after 2 years. High age, male sex and comorbidity were the strongest risk factors for AMI. Older patients (>70 years) with mild comorbidities (i.e. hypertension or diabetes) had a 61% higher AMI rate than comparators (HR: 1.61, 95% CI: 1.10-2.35), whereas the corresponding excess rate was 28% for patients with severe comorbidities (HR: 1.28, 95% CI: 1.01-1.64). Among younger patients (<= 70), a short-term excess rate of AMI was limited to those with severe comorbidities. There was no difference in AMI characteristics, pharmacological treatment or 30-day survival among patients and comparators. Conclusion DLBCL patients have an increased risk of AMI, especially during the first 2 years, which calls for improved cardiac monitoring guided by age and comorbidities. Importantly, DLBCL was not associated with differential AMI management or survival.
More
Translated text
Key words
acute myocardial infarction,cardiology,epidemiology,lymphoma
求助PDF
上传PDF
Bibtex
收藏
AI Read Science
AI Summary
AI Summary is the key point extracted automatically understanding the full text of the paper, including the background, methods, results, conclusions, icons and other key content, so that you can get the outline of the paper at a glance.
Example
Background
Key content
Introduction
Methods
Results
Related work
Fund
Key content
  • Pretraining has recently greatly promoted the development of natural language processing (NLP)
  • We show that M6 outperforms the baselines in multimodal downstream tasks, and the large M6 with 10 parameters can reach a better performance
  • We propose a method called M6 that is able to process information of multiple modalities and perform both single-modal and cross-modal understanding and generation
  • The model is scaled to large model with 10 billion parameters with sophisticated deployment, and the 10 -parameter M6-large is the largest pretrained model in Chinese
  • Experimental results show that our proposed M6 outperforms the baseline in a number of downstream tasks concerning both single modality and multiple modalities We will continue the pretraining of extremely large models by increasing data to explore the limit of its performance
Upload PDF to Generate Summary
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn
Chat Paper

要点】:本研究发现弥漫大B细胞淋巴瘤(DLBCL)患者心肌梗死(AMI)的风险增加33%,尤其是在诊断后的前两年,强调了对这部分人群需要进行年龄和合并症指导的心脏监测。

方法】:通过瑞典的人口基础登记,对2007年至2014年间被诊断为DLBCL并接受治疗的3548名患者与35474名匹配的一般人群对照者进行急性心肌梗死的发病率、特征及预后评估。

实验】:使用人口基础登记数据,对DLBCL患者和对照人群进行了长达11年的跟踪,通过灵活的参数模型估计AMI的发病率。结果显示,与一般人群相比,DLBCL患者在总体上AMI的超出风险为33%,其中高龄、男性和合并症是AMI最强的风险因素。在年龄大于70岁且合并症较轻的患者中,AMI的风险增加了61%;而在较年轻的患者中,AMI的短期风险仅限于合并症严重者。患者与对照者在AMI的特征、药物治疗或30天生存率上没有差异。